HEALTHCARE RESOURCE UTILIZATION IN PATIENTS TREATED WITH EMPAGLIFLOZIN IN EAST ASIA: RESULTS FROM EMPRISE STUDY

被引：0
|
作者：
Sheu, Wayne [1 ]
Seino, Yutaka [1 ]
Tan, Elise [1 ]
Yabe, Daisuke [1 ]
Ha, Kyoung Hwa [1 ]
Chung, Wook-Jin [1 ]
Taneda, Yusuke [1 ]
Lei, Wei-Yu [1 ]
Ustyugova, Anastasia [1 ]
Klement, Riho [1 ]
Deruaz-Luyet, Anouk [1 ]
Kyaw, Moe [1 ]
Kim, Dae Jung [1 ]
机构：
[1] Boehringer Ingelheim Pharmaceut Inc, EMPRISE East Asia Study Grp, 90 E Ridge POB 368, Ridgefield, CT 06877 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2021年 / 77卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1470 / 1470
页数：1
相关论文
共 50 条
  • [41] Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia
    Vistisen, Dorte
    Carstensen, Bendix
    Elisabetta, Patorno
    Lanzinger, Stefanie
    Tan, Elise Chia-Hui
    Yabe, Daisuke
    Kim, Dae Jung
    Sheu, Wayne H. -H.
    Melzer-Cohen, Cheli
    Holl, Reinhard W.
    Nunez, Julio
    Ha, Kyoung Hwa
    Halvorsen, Sigrun
    Langslet, Gisle
    Karasik, Avraham
    Nystrom, Thomas
    Niskanen, Leo
    Guleria, Sonia
    Klement, Riho
    Carrasco, Marc
    Foersch, Johannes
    Shay, Christina
    Koeneman, Lisette
    Hoti, Fabian
    Farsani, Soulmaz Fazeli
    Khunti, Kamlesh
    Zaccardi, Francesco
    Subramanian, Anuradhaa
    Nirantharakumar, Krishnarajah
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [42] Empagliflozin and Risk of Incident Gout: Analysis from the EMPagliflozin Comparative Effectiveness and SafEty (EMPRISE) Cohort Study
    Tesfaye, Helen
    Wang, Katherine M.
    Zabotka, Luke E.
    Wexler, Deborah J.
    Schmedt, Niklas
    Koeneman, Lisette
    Seman, Leo
    Paik, Julie M.
    Patorno, Elisabetta
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2024, 39 (10) : 1870 - 1879
  • [43] HEALTHCARE RESOURCE UTILIZATION AND COSTS BY CARDIOVASCULAR RISK LEVEL: RESULTS FROM THE LATINO STUDY
    Afonso-Silva, M.
    Gavina, C.
    Seabra, D.
    Araujo, F.
    Grangela, D.
    Taveira-Gomes, T.
    VALUE IN HEALTH, 2022, 25 (12) : S153 - S153
  • [44] Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia
    Dorte Vistisen
    Bendix Carstensen
    Patorno Elisabetta
    Stefanie Lanzinger
    Elise Chia-Hui Tan
    Daisuke Yabe
    Dae Jung Kim
    Wayne H.-H. Sheu
    Cheli Melzer-Cohen
    Reinhard W. Holl
    Júlio Núñez
    Kyoung Hwa Ha
    Sigrun Halvorsen
    Gisle Langslet
    Avraham Karasik
    Thomas Nyström
    Leo Niskanen
    Sonia Guleria
    Riho Klement
    Marc Carrasco
    Johannes Foersch
    Christina Shay
    Lisette Koeneman
    Fabian Hoti
    Soulmaz Fazeli Farsani
    Kamlesh Khunti
    Francesco Zaccardi
    Anuradhaa Subramanian
    Krishnarajah Nirantharakumar
    Cardiovascular Diabetology, 22
  • [45] Empagliflozin reduces cardiorenal events, healthcare resource use and mortality in Sweden compared to dipeptidyl peptidase-4 inhibitors: Real world evidence from the Nordic EMPRISE study
    Nystrom, Thomas
    Toresson Grip, Emilie
    Gunnarsson, Joel
    Casajust, Paula
    Karlsdotter, Kristina
    Skogsberg, Josefin
    Ustyugova, Anastasia
    DIABETES OBESITY & METABOLISM, 2023, 25 (01): : 261 - 271
  • [46] HEALTHCARE RESOURCE UTILIZATION IN TREATED OBSTRUCTIVE SLEEP APNEA PATIENTS WITH COMORBID INSOMNIA
    Pepin, Jean-Louis
    Malik, Anita
    Woodford, Caleb
    Malhotra, Atul
    Sterling, Kimberly
    Cistulli, Peter
    McConnell, Will
    Alpert, Naomi
    Cole, Kate
    SLEEP, 2024, 47
  • [47] Healthcare resource utilization (HRU) in treated mantle cell lymphoma (MCL) patients
    Kozma, Chris M.
    Slaton, Terra
    Ellis, Lorie
    McKenzie, R. S.
    CANCER RESEARCH, 2014, 74 (19)
  • [48] Obesity and healthcare resource utilization: comparative results from the UK and the USA
    Nortoft, E.
    Chubb, B.
    Borglykke, A.
    OBESITY SCIENCE & PRACTICE, 2018, 4 (01): : 41 - 45
  • [49] Cardiorenal Effectiveness of Empagliflozin vs. GLP-1 Receptor Agonists in Patients with Advanced Chronic Kidney Disease: Results from the EMPRISE study
    Koenemann, Lisette
    Htoo, Phyo Than
    Patorno, Elisabetta
    Tesfaye, Helen
    Wexler, Deborah J.
    Glynn, Robert J.
    Schmedt, Niklas
    Deruaz-Luyet, Anouk
    Schneeweiss, Sebastian
    Paik, Julie M.
    INNERE MEDIZIN, 2024, 65 : S149 - S149
  • [50] Healthcare Resource Utilization and Health-related Quality of Life in Adult Patients With Chronic Migraine: Results From the PREDICT Study
    Boudreau, G.
    Finkelstein, I
    Graboski, C.
    Ong-Lam, M.
    Christie, S.
    Sommer, K.
    Bhogal, M.
    Davidovic, G.
    Becker, W. J.
    HEADACHE, 2020, 60 : 16 - 17
12345